Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Pimm

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Life Sciences|January 1, 1994
Possible consequences of human antibody responses on the biodistribution of fragments of human, humanized or chimeric monoclonal antibodies: a note of cautionM V Pimm
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1988
Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitationsM V Pimm
Nuclear Medicine Communications|August 1, 1995
Preventing renal uptake of 111In from labelled monoclonal antibody fragmentsM V Pimm
British Journal of Cancer|August 1, 1974
Proceedings: B.C.G. treatment of pleural and peritoneal tumour growth in ratsM V Pimm
British Journal of Cancer|July 1, 1990
An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenograftsM V Pimm
Lancet (London, England)|July 10, 1976
Letter: Intrapleural B.C.G. treatment of experimental lung tumoursM V Pimm
Nuclear Medicine and Biology|February 1, 1995
Circulating antigen: bad or good for immunoscintigraphy?M V Pimm
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteinsM V Pimm, F Hudecz
Advances in Cancer Research|January 1, 1978
BCG in tumor immunotherapyR W Baldwin, M V Pimm
European Journal of Cancer|January 1, 1980
Kinetics of BCG mediated tumour cell destruction in the ratM V Pimm, R W Baldwin
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Life Sciences|January 1, 1994
Possible consequences of human antibody responses on the biodistribution of fragments of human, humanized or chimeric monoclonal antibodies: a note of cautionM V Pimm
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1988
Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitationsM V Pimm
Nuclear Medicine Communications|August 1, 1995
Preventing renal uptake of 111In from labelled monoclonal antibody fragmentsM V Pimm
British Journal of Cancer|August 1, 1974
Proceedings: B.C.G. treatment of pleural and peritoneal tumour growth in ratsM V Pimm
British Journal of Cancer|July 1, 1990
An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenograftsM V Pimm
Lancet (London, England)|July 10, 1976
Letter: Intrapleural B.C.G. treatment of experimental lung tumoursM V Pimm
Nuclear Medicine and Biology|February 1, 1995
Circulating antigen: bad or good for immunoscintigraphy?M V Pimm
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteinsM V Pimm, F Hudecz
Advances in Cancer Research|January 1, 1978
BCG in tumor immunotherapyR W Baldwin, M V Pimm
European Journal of Cancer|January 1, 1980
Kinetics of BCG mediated tumour cell destruction in the ratM V Pimm, R W Baldwin
Pageof 16